Efficacy and safety assessment of apatinib in patients with advanced gastric cancer: a meta-analysis

AIM: This meta-analysis was performed to evaluate the efficacy and safety of apatinib in patients with advanced gastric cancer (AGC). METHODS: After evaluating the inclusion and exclusion criteria, the data of eligible randomized clinical trials (RCTs) were extracted. Outcomes including objective re...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jianxin, Wang, Junhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056163/
https://www.ncbi.nlm.nih.gov/pubmed/30050306
http://dx.doi.org/10.2147/OTT.S157466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056163/
https://www.ncbi.nlm.nih.gov/pubmed/30050306
http://dx.doi.org/10.2147/OTT.S157466

Ejemplares similares